The reported study showed that it is a tumor suppressor in non-small cell lung cancer.[8] Moreover, the activity of LRP1B is commonly down-regulated during the process of the development of many kinds of cancer, for instance, renal and colon cancer. This evidence concerns the gene LRP1B and colonic neoplasm.